Expression of FOXM1 and PLK1 in Colorectal Cancer and Their Relationship with Clinicopathological Features and Prognosis
ObjectiveTo determine the expression of FOXM1 and PLK1 in colorectal cancer tissues and their relationship with clinicopathological characteristics and prognosis of patients. MethodsSixty patients who underwent surgical resection of colorectal cancer were retrospectively selected. Colorectal cancer...
Saved in:
| Main Authors: | Xue HAN, Shuqing LIU, Jiangling YIN, Changcheng WANG |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Magazine House of Cancer Research on Prevention and Treatment
2025-07-01
|
| Series: | Zhongliu Fangzhi Yanjiu |
| Subjects: | |
| Online Access: | http://www.zlfzyj.com/cn/article/doi/10.3971/j.issn.1000-8578.2025.24.1284 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The status of p53 affects the efficacy of PLK1 inhibitor BI6727 in prostate cancer cells
by: Wenjing Li, et al.
Published: (2025-07-01) -
PLK1 inhibition impairs erythroid differentiation
by: Peijun Jia, et al.
Published: (2024-12-01) -
Pin1–FOXM1 inhibitors: a potential therapeutic for metastatic melanoma?
by: Peter LJ de Keizer
Published: (2016-09-01) -
FOXM1 could serve as a bridge mediating prognosis and immunity for clear cell renal cell carcinoma via single-cell and bulk RNA-sequencing
by: Jianhua Zhou, et al.
Published: (2025-04-01) -
Discovery of novel dual-targeting inhibitors against PLK1-PBD and PLK4-PB3: structure-guided pharmacophore modelling, virtual screening, molecular docking, molecular dynamics simulation, and biological evaluation
by: Changhao Zhao, et al.
Published: (2025-12-01)